Dr Reddy's Labs Gains on Launching Drug for Stroke Patients

Shares of Dr Reddy's Labs jumped nearly 3 per cent to hit intraday high of Rs 3,591.80 after the company on Friday said that it has launched a drug for treatment of post-stroke patients. Dr Reddy's Labs has launched Somazina in the Indian markets. the drug's is innovator brand is Citicoline. Dr. Reddy's has partnered with the global innovator of Citicoline, Ferrer Internacional S.A., Spain, to make Somazina available in India. Soma...